BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16574293)

  • 1. Improvement of tardive dyskinesia following amisulpride treatment.
    Peritogiannis V; Tsouli S; Zafiris S; Pappas D; Mavreas V
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):748-50. PubMed ID: 16574293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of tardive dyskinesia in a patient taking amisulpride.
    Masdrakis VG; Papadimitriou GN; Papageorgiou C; Kouzoupis A; Giailoglou D; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):586-7. PubMed ID: 17196725
    [No Abstract]   [Full Text] [Related]  

  • 4. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic bradycardia associated with amisulpride.
    Pedrosa Gil F; Grohmann R; Rüther E
    Pharmacopsychiatry; 2001 Nov; 34(6):259-61. PubMed ID: 11778148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride-induced tardive dyskinesia.
    Fountoulakis KN; Panagiotidis P; Siamouli M; Kantartzis S; Mavridis T; Iacovides A; Kaprinis G
    Schizophr Res; 2006 Dec; 88(1-3):232-4. PubMed ID: 16963229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary incontinence associated with amisulpride.
    Mendhekar D; Lohia D
    World J Biol Psychiatry; 2009; 10(4 Pt 3):1045-6. PubMed ID: 18609424
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
    Chen YY; Huang MC; Wu KC
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
    [No Abstract]   [Full Text] [Related]  

  • 11. Amisulpride treatment for clozapine-induced sialorrhea.
    Praharaj SK; Sarkar S; Sinha VK
    J Clin Psychopharmacol; 2009 Apr; 29(2):189-90. PubMed ID: 19512987
    [No Abstract]   [Full Text] [Related]  

  • 12. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.
    Opgen-Rhein C; Neuhaus AH; Dettling M
    J Clin Psychopharmacol; 2007 Feb; 27(1):92-3. PubMed ID: 17224723
    [No Abstract]   [Full Text] [Related]  

  • 14. Tardive dyskinesias and antipsychotics: a review.
    Llorca PM; Chereau I; Bayle FJ; Lancon C
    Eur Psychiatry; 2002 May; 17(3):129-38. PubMed ID: 12052573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride therapeutic dose-induced asymptomatic bradycardia.
    Prikryl R; Ustohal L; Prikrylova-Kucerova H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):290. PubMed ID: 20965224
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive oculogyric crisis associated with amisulpride monotherapy.
    Mendhekar DN; Lohia D; Kataria P
    J Postgrad Med; 2010; 56(4):305-6. PubMed ID: 20935407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
    Rettenbacher MA; Hummer M; Fleischhacker WW; Lechleitner M
    J Clin Psychiatry; 2004 Jun; 65(6):878-9. PubMed ID: 15291669
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of metoclopramide hydrochloride in patients with residual schizophrenia with tardive dyskinesias].
    Kiehl U; Nitzsche M; Fischer GJ
    Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):722-6. PubMed ID: 2869538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride-induced tardive motor and phonic tics.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2006; 29(3):163-4. PubMed ID: 16772818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.